相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Specific, reversible G1 arrest by UCN-01 in vivo provides cytostatic protection of normal cells against cytotoxic chemotherapy in breast cancer
Benjamin B. Mull et al.
BRITISH JOURNAL OF CANCER (2020)
Heterogeneity of Circulating Tumor Cells in Breast Cancer: Identifying Metastatic Seeds
Maxim E. Menyailo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Behavior of metastatic breast cancer according to subtype
Margot Van Mechelen et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
TCRP1 induces tamoxifen resistance by promoting the activation of SGK1 in MCF-7 cells
Shuai Zhao et al.
ONCOLOGY REPORTS (2020)
Regulation of breast cancer metastasis signaling by miRNAs
Belinda J. Petri et al.
CANCER AND METASTASIS REVIEWS (2020)
Myeloid deletion of phosphoinositide-dependent kinase-1 enhances NK cell-mediated antitumor immunity by mediating macrophage polarization
Yuexi He et al.
ONCOIMMUNOLOGY (2020)
A patent update on PDK1 inhibitors (2015-present)
Simona Sestito et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2019)
MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer
Yueh-Shan Weng et al.
MOLECULAR CANCER (2019)
MiR-873/PD-L1 axis regulates the stemness of breast cancer cells
Lanlan Gao et al.
EBIOMEDICINE (2019)
Chemotherapy-Induced Extracellular Vesicle miRNAs Promote Breast Cancer Stemness by Targeting ONECUT2
Meng Shen et al.
CANCER RESEARCH (2019)
Low expression of PDK1 inhibits renal cell carcinoma cell proliferation, migration, invasion and epithelial mesenchymal transition through inhibition of the PI3K-PDK1-Akt pathway
Wei-Min Zhou et al.
CELLULAR SIGNALLING (2019)
Metastasis Organotropism: Redefining the Congenial Soil
Yang Gao et al.
DEVELOPMENTAL CELL (2019)
Ponatinib Inhibits Proliferation and Induces Apoptosis of Liver Cancer Cells, but Its Efficacy Is Compromised by Its Activation on PDK1/Akt/mTOR Signaling
Chang Liu et al.
MOLECULES (2019)
Mapping phospho-catalytic dependencies of therapy-resistant tumours reveals actionable vulnerabilities
Jean-Philippe Coppe et al.
NATURE CELL BIOLOGY (2019)
The Role of Exosomal MicroRNAs in the Tumor Microenvironment of Breast Cancer
Qingqing Liu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The Regulatory Role of MicroRNAs in Breast Cancer
Hui-Yi Loh et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
MicroRNAs Contribute to Breast Cancer Invasiveness
Ivana Fridrichova et al.
CELLS (2019)
MicroRNAs Involved in Carcinogenesis, Prognosis, Therapeutic Resistance, and Applications in Human Triple-Negative Breast Cancer
Lei Ding et al.
CELLS (2019)
Breast cancer lung metastasis: Molecular biology and therapeutic implications
Liting Jin et al.
CANCER BIOLOGY & THERAPY (2018)
microRNA-155 positively regulates glucose metabolism via PIK3R1-FOXO3a-cMYC axis in breast cancer
Sinae Kim et al.
ONCOGENE (2018)
Cancer-secreted hsa-miR-940 induces an osteoblastic phenotype in the bone metastatic microenvironment via targeting ARHGAP1 and FAM134A
Kyoko Hashimoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
AGC kinases in cancer metastasis, immune checkpoint regulation and drug resistance
Gongda Xue et al.
SEMINARS IN CANCER BIOLOGY (2018)
PDK1: At the crossroad of cancer signaling pathways
Paolo Armando Gagliardi et al.
SEMINARS IN CANCER BIOLOGY (2018)
Targeting the BRD4/FOXO3a/CDK6 axis sensitizes AKT inhibition in luminal breast cancer
Jingyi Liu et al.
NATURE COMMUNICATIONS (2018)
Identification of single nucleotide polymorphisms of the PI3K-AKT-mTOR pathway as a risk factor of central nervous system metastasis in metastatic breast cancer
Emilie Le Rhun et al.
EUROPEAN JOURNAL OF CANCER (2017)
Serine/Threonine Kinase 3-Phosphoinositide-Dependent Protein Kinase-1 (PDK1) as a Key Regulator of Cell Migration and Cancer Dissemination
Laura Di Blasio et al.
CANCERS (2017)
Kinome-Wide RNA Interference Screen Reveals a Role for PDK1 in Acquired Resistance to CDK4/6 Inhibition in ER-Positive Breast Cancer
Valerie M. Jansen et al.
CANCER RESEARCH (2017)
PDK1 promotes tumor growth and metastasis in a spontaneous breast cancer model
J. Du et al.
ONCOGENE (2016)
PDK1-SGK1 Signaling Sustains AKT-Independent mTORC1 Activation and Confers Resistance to PI3Kα Inhibition
Pau Castel et al.
CANCER CELL (2016)
A Small Molecule Inhibitor of PDK1/PLCγ1 Interaction Blocks Breast and Melanoma Cancer Cell Invasion
Claudio Raimondi et al.
SCIENTIFIC REPORTS (2016)
AMIGO2, a novel membrane anchor of PDK1, controls cell survival and angiogenesis via Akt activation
Hyojin Park et al.
JOURNAL OF CELL BIOLOGY (2015)
Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood-brain barrier
Naoomi Tominaga et al.
NATURE COMMUNICATIONS (2015)
Cancer metastases: challenges and opportunities
Xiangming Guan
ACTA PHARMACEUTICA SINICA B (2015)
Cancer-Secreted miR-105 Destroys Vascular Endothelial Barriers to Promote Metastasis
Weiying Zhou et al.
CANCER CELL (2014)
Immunohistochemical analysis of PDK1 expression in breast cancer
Ruza Arsenic
DIAGNOSTIC PATHOLOGY (2014)
The phosphoinositide-dependent protein kinase 1 inhibitor, UCN-01, induces fragmentation: Possible role of metalloproteinases
Rocio Alcantara-Hernandez et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
PDK1-mediated activation of MRCKα regulates directional cell migration and lamellipodia retraction
Paolo Armando Gagliardi et al.
JOURNAL OF CELL BIOLOGY (2014)
miR-200-containing extracellular vesicles promote breast cancer cell metastasis
Minh T. N. Le et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Identification of mTORC2 as a Necessary Component of HRG/ErbB2-Dependent Cellular Transformation
Miao-chong J. Lin et al.
MOLECULAR CANCER RESEARCH (2014)
Elevated SGK1 predicts resistance of breast cancer cells to Akt inhibitors
Eeva M. Sommer et al.
BIOCHEMICAL JOURNAL (2013)
A phase II study of UCN-01 in combination with irinotecan in patients with metastatic triple negative breast cancer
Cynthia X. Ma et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Single Copies of Mutant KRAS and Mutant PIK3CA Cooperate in Immortalized Human Epithelial Cells to Induce Tumor Formation
Grace M. Wang et al.
CANCER RESEARCH (2013)
PDK1 Signaling Toward PLK1-MYC Activation Confers Oncogenic Transformation, Tumor-Initiating Cell Activation, and Resistance to mTOR-Targeted Therapy
Jing Tan et al.
CANCER DISCOVERY (2013)
An heregulin-EGFR-HER3 autocrine signaling axis can mediate acquired lapatinib resistance in HER2+breast cancer models
Wenle Xia et al.
BREAST CANCER RESEARCH (2013)
A novel regulatory mechanism links PLCγ1 to PDK1
Claudio Raimondi et al.
JOURNAL OF CELL SCIENCE (2012)
Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models
Cynthia X. Ma et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Proliferative and Antiapoptotic Signaling Stimulated by Nuclear-Localized PDK1 Results in Oncogenesis
Chintan K. Kikani et al.
SCIENCE SIGNALING (2012)
3-Phosphoinositide-Dependent Kinase 1 Controls Breast Tumor Growth in a Kinase-Dependent but Akt-Independent Manner
Paolo Armando Gagliardi et al.
NEOPLASIA (2012)
PDK1 inhibitors
Elisa Barile et al.
PHARMACEUTICAL PATENT ANALYST (2012)
Perspectives in PDK1 evolution Insights from photosynthetic and non-photosynthetic organisms
Anna C. Nelson Dittrich et al.
PLANT SIGNALING & BEHAVIOR (2012)
Characterization of GSK2334470, a novel and highly specific inhibitor of PDK1
Ayaz Najafov et al.
BIOCHEMICAL JOURNAL (2011)
Light at Night Activates IGF-1R/PDK1 Signaling and Accelerates Tumor Growth in Human Breast Cancer Xenografts
Jinghai Wu et al.
CANCER RESEARCH (2011)
Genetic and Pharmacological Inhibition of PDK1 in Cancer Cells CHARACTERIZATION OF A SELECTIVE ALLOSTERIC KINASE INHIBITOR
Kumiko Nagashima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Phosphoinositide 3-kinase signaling pathway mediated by p110α regulates invadopodia formation
Hideki Yamaguchi et al.
JOURNAL OF CELL BIOLOGY (2011)
3-Phosphoinositide-Dependent Protein Kinase-1 Regulates Proliferation and Survival of Cancer Cells with an Activated Mitogen-Activated Protein Kinase Pathway
Zhuomei Lu et al.
MOLECULAR CANCER RESEARCH (2010)
Molecular Pharmacology and Antitumor Activity of PHT-427, a Novel Akt/Phosphatidylinositide-Dependent Protein Kinase 1 Pleckstrin Homology Domain Inhibitor
Emmanuelle J. Meuillet et al.
MOLECULAR CANCER THERAPEUTICS (2010)
The nuts and bolts of AGC protein kinases
Laura R. Pearce et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Parallel RNAi and compound screens identify the PDK1 pathway as a target for tamoxifen sensitization
Elizabeth Iorns et al.
BIOCHEMICAL JOURNAL (2009)
3-Phosphoinositide-Dependent Kinase 1 Potentiates Upstream Lesions on the Phosphatidylinositol 3-Kinase Pathway in Breast Carcinoma
Matthew Maurer et al.
CANCER RESEARCH (2009)
Phosphoinositide-dependent kinase 1 controls migration and malignant transformation but not cell growth and proliferation in PTEN-null lymphocytes
David K. Finlay et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Down-Regulation of 3-Phosphoinositide-Dependent Protein Kinase-1 Levels Inhibits Migration and Experimental Metastasis of Human Breast Cancer Cells
Ying Liu et al.
MOLECULAR CANCER RESEARCH (2009)
PDK1 regulates cancer cell motility by antagonising inhibition of ROCK1 by RhoE
Sophie Pinner et al.
NATURE CELL BIOLOGY (2008)
Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?
Witold Filipowicz et al.
NATURE REVIEWS GENETICS (2008)
Notch-induced T cell development requires phosphoinositide-dependent kinase 1
April P. Kelly et al.
EMBO JOURNAL (2007)
Mechanism for activation of the growth factor-activated AGC kinases by turn motif phosphorylation
Camilla Hauge et al.
EMBO JOURNAL (2007)
Overcoming trastuzumab resistance in HER2-overexpressing breast cancer cells by using a novel celecoxib-derived phosphoinositide-dependent kinase-1 inhibitor
Ping-Hui Tseng et al.
MOLECULAR PHARMACOLOGY (2006)
Differential roles of phosphoinositide-dependent protein kinase-1 and Akt1 expression and phosphorylation in breast cancer cell resistance to paclitaxel, doxorubicin, and gemcitabine
Ke Liang et al.
MOLECULAR PHARMACOLOGY (2006)
3-Phosphoinositide-dependent Protein Kinase-1 (PDK1) promotes invasion and activation of matrix metalloproteinases
Zhihui Xie et al.
BMC CANCER (2006)
Elevated phosphorylation and activation of PDK-I/AKT pathway in human breast cancer
HJ Lin et al.
BRITISH JOURNAL OF CANCER (2005)
Phosphoinositide-dependent phosphorylation of PDK1 regulates nuclear translocation
MP Scheid et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
DD Sarbassov et al.
SCIENCE (2005)
The serine kinase phosphoinositide-dependent kinase 1 (PDK1) regulates T cell development
HJ Hinton et al.
NATURE IMMUNOLOGY (2004)
PDK1, the master regulator of AGC kinase signal transduction
A Mora et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2004)
Phosphoinositide-dependent protein kinase 1, a sensor of protein conformation
RM Biondi
TRENDS IN BIOCHEMICAL SCIENCES (2004)
Nuclear translocation of 3′-phosphoinositide-dependent protein kinase 1 (PDK-1):: A potential regulatory mechanism for PDK-1 function
MA Lim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Structural basis for UCN-01 (7-hydroxystaurosporine) specificity and PDK1 (3-phosphoinositide-dependent protein kinase-1) inhibition
D Komander et al.
BIOCHEMICAL JOURNAL (2003)
In vivo role of the PIF-binding docking site of PDK1 defined by knock-in mutation
BJ Collins et al.
EMBO JOURNAL (2003)
Vascular endothelial growth factor modulates the transendothelial migration of MDA-MB-231 breast cancer cells through regulation of brain microvascular endothelial cell permeability
TH Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Pyk2- and Src-dependent tyrosine phosphorylation of PDK1 regulates focal adhesions
Y Taniyama et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Binding of phosphatidylinositol 3,4,5-trisphosphate to the pleckstrin homology domain of protein kinase B induces a conformational change
CC Milburn et al.
BIOCHEMICAL JOURNAL (2003)
High resolution crystal structure of the human PDK1 catalytic domain defines the regulatory phosphopeptide docking site
RM Biondi et al.
EMBO JOURNAL (2002)
Identification of tyrosine phosphorylation sites on 3-phosphoinositide-dependent protein kinase-1 and their role in regulating kinase activity
J Park et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Inhibition of PDK-1 activity causes a reduction in cell proliferation and survival
P Flynn et al.
CURRENT BIOLOGY (2000)
Peroxovanadate induces tyrosine phosphorylation of phosphoinositide-dependent protein kinase-1 -: Potential involvement of Src kinase
S Grillo et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2000)
Identification of a pocket in the PDK1 kinase domain that interacts with PIF and the C-terminal residues of PKA
RM Biondi et al.
EMBO JOURNAL (2000)
Enhancement of camptothecin-induced cytotoxicity with UCN-01 in breast cancer cells: abrogation of S/G(2) arrest
CB Jones et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2000)
分享论文
